This study helps us to understand how the infiltrative patterns of glioblastoma contribute to patient outcomes. The invasive subregion identified by this approach may have clinical implications for personalized surgical resection and targeted radiation therapy.
Introduction
Glioblastoma is the commonest primary malignant tumor in the central nervous system of adults (1) . It is among the most lethal cancers, characterized by diffuse infiltration into the normal brain tissue (2) , which renders a total resection impossible.
Progression after surgery is almost inevitable, and predominantly manifest adjacent to the resection cavity (3).
It is recognized that glioblastoma is heterogeneous in its infiltrative pattern. Some tumors may disseminate into the surrounding brain tissue earlier and more intensively (4) . Recent genomic findings have revealed that multiple tumor clones coexist in the same tumor and may display diverse biological traits (5, 6) . Migratory clones may contribute to a more diffuse and invasive phenotype, which is thought to be especially responsible for treatment failure (3) . Therefore, understanding the intratumoral heterogeneity of glioblastoma infiltration is of clinical significance for targeted surgery and radiotherapy.
Magnetic resonance imaging (MRI) has unique advantages in understanding spatial variations within glioblastoma. Current clinical management is primarily based on structural sequences, among which the contrast enhancement on post-contrast T1-weighted imaging is most widely-used. However, these findings are limited since it just reflects the failure of blood brain barrier. Other sequences, such as fluid attenuated inversion recovery (FLAIR), although have been combined in patient assessment (7) , but still proved to be non-specific in detecting tumor infiltration (8) .
Diffusion tensor imaging (DTI), a method that measures the magnitude and direction of water molecule movement, has shown its sensitivity in detecting tumor infiltration (9) . Glioblastoma is recognized to preferentially migrate along the white matter tracts and causes disruption to the microstructure of the tracts (10) . The diffusion of water molecules in the tumor core and peritumoral brain tissue is consequently altered. By decomposing the tensor into isotropic (DTI-p) and anisotropic (DTI-q) components, the directional diffusion of water molecules can be measured (11) . This approach has been identified to be useful in predicting tumor progression (4) and patient survival (12) . However, it remains to be discovered if integrating these decomposed components can offer a more comprehensive measure of tumor infiltration.
Furthermore, several molecular biomarkers, such as isocitrate dehydrogenase (IDH) mutations (13) and oxygen 6-methylguanine-DNA methyltransferase (MGMT) promoter methylation (14) have been reported to be of diagnostic and prognostic significance for glioblastoma. Whether these DTI markers, particularly DTI-p and -q, can provide additional value to molecular markers is still unclear.
The purpose of this study is to propose a novel interpretation method of DTI by using the joint histogram analysis of DTI-p and -q. With this method we explored the heterogeneity of tumor infiltration and examined the prognostic value of tumor infiltrative patterns for patient survival. Our hypothesis was that the joint histogram analysis of DTI-p and -q would provide: 1) a more comprehensive measure of heterogeneity of tumor infiltration; 2) a more accurate detection of infiltrative subregions which are more responsible for tumor progression; and 3) incremental prognostic values for glioblastoma patients when integrated with IDH-1 mutation, MGMT methylation status and other clinical factors.
Methods

Patient population
This study was approved by the local institutional review board. Signed informed consent was obtained from all patients. A total of 136 patients with supratentorial primary glioblastoma were prospectively recruited for surgical resection from July 2010 to August 2015. All patients displayed good performance status (World Health Organization performance status 0-1). Exclusion criteria included history of a previous brain tumor, cranial surgery, radiotherapy/chemotherapy, or contraindication for MRI scanning. To achieve maximal safe resection, tumor resection was performed with the guidance of neuronavigation (StealthStation, Medtronic) and 5-aminolevulinic acid fluorescence (5-ALA). After surgery, 115 (84.6%) histologically confirmed glioblastoma patients (mean age 59.3 years, range 22 -76 years, 87 males) were included. Twenty-one patients were excluded due to the non-glioblastoma pathology diagnosis.
Chemoradiotherapy was performed when patients were stable after surgery, Extent of resection was assessed according to the postoperative MRI scans within 72 hours, classified as either gross total resection, subtotal resection or biopsy of the contrast enhanced tumor region. Patients were followed up in our neuro-oncology clinics.
Treatment response and tumor progression was evaluated according to the Response Assessment in Neuro-oncology criteria (7) . All MRI and histological data were collected prospectively, whereas survival data were analyzed retrospectively to avoid the issue of pseudoprogression. Among the cohort, 31 of 115 (27.0%) patients were previously included in a study which reported the utility of diffusion abnormalities for indication of extent of resection (15) ; 50 of 115 (43.5%) patients were reported to reveal the diffusion and metabolic change in peritumoral area glioblastoma (16) ; 64 of 115 (55.7%) patients were reported in another study which identified the correlation between a less invasive phenotype with IDH mutation (17) .
This current manuscript reports a novel approach using joint histogram analysis of tensor decomposition to explore the intratumoral heterogeneity of glioblastoma. 
Pro-operative MRI acquisition
Imaging processing
For each subject, DTI images were firstly processed with the diffusion toolbox (FDT) (19) . Inter-rater reliability testing was performed using Dice similarity coefficient scores.
Histogram analysis
Both univariate and joint histogram analysis were performed in the Statistics and 
The proportion of each voxel group in the ROI (calculated as the summed voxels divided by the total ROI volume) were used as the joint histogram features. These joint histogram features were obtained from both contrast-enhancing and nonenhancing tumor regions, leading to 8 features for each patient.
Assessment of IDH-1 R132H Mutation and MGMT Methylation Status
IDH-1 R132H mutation was firstly evaluated via immunohistochemistry. After the paraffin was removed and a heat-induced antigen retrieval was performed, IDH-1 R132H mutation-specific antibody (Dianova, Hamburg, Germany) was applied at a 1:20 dilution on slices. A secondary antibody avidin-based detection system was used. In five patients for whom IDH-1 R132H mutation was not detected by MGMT promoter methylation status was evaluated as follows: DNA was extracted from the dissected neoplastic cell-rich tissue and was bisulphite-converted using the EpiTect Bisulphite Kit (Qiagen). Pyrosequencing of four CpG sites (CpGs 76-79) in exon 1 of the MGMT gene was then performed by using the CE-Marked therascreen MGMT Pyro Kit on a Pyromark Q24 System (Qiagen). A cut-off of 10% mean methylation for the four CpG sites was used to determine tumors as either methylated or unmethylated based on the published data (22, 23) .
Evaluation of tumor progression rate
Tumor progression was diagnosed in our neuro-oncology clinics by the multidisciplinary team. The time to progression was defined as the time period between the surgery date and the date of the first MRI T1W image with contrast that showed tumour progression (as determined by a consultant neuroradiologist).
Available tumor progression images were collected by one of the authors (JLY, a neurosurgeon with > 10 years of experience) and reviewed by three authors (CL, JLY and RJP). A two-stage semiautomatic coregistration between the progression images and pre-operative postcontrast T1-weighted images was performed using a previously reported tool (24). This coregistration method firstly calculated the transformation matrix between the pre-operative lesion and tumor cavity on progression images. The matrix was then applied to the brain parenchyma (15) . After coregistration, the progression tumor volume was calculated using FSL function of fslmaths. The progression rate was calculated as the progression tumor volume divided by time to progression.
Statistics
All analyses were performed in RStudio v3. Characteristics (ROC) curves were generated and the area under the curve (AUC)
were compared using one-way ANOVA. For the Kaplan-Meier analysis, the continuous variables were dichotomized using optimal cutoff values, which were calculated by the function of 'surv_cutpoint' in R Package "survminer". Significance was accepted at a two-sided significance level of alpha < 0.05. 
Results
Patients and regions of interest
Diffusion signatures of contrast-enhancing and non-enhancing regions
The diffusion signatures of contrast-enhancing and non-enhancing regions are demonstrated in Table 2 . The comparisons of all histogram features between contrast-enhancing and non-enhancing regions showed significance (each p < 0.01), suggesting the two regions had distinct diffusion patterns. For the univariate features, both contrast-enhancing and non-enhancing regions displayed increased DTI-p (with a value of all >greater than 1), compared to normal-appearing white matter, although the increase in contrast-enhancing region is more significant. A consistently decreased DTI-q (with a value of less than 1) was observed in contrast-enhancing region, whereas non-enhancing region displayed increased mean and 75th percentile in DTI-q. Generally, contrast-enhancing region displayed a more significantly increased DTI-p and decreased DTI-q than non-enhancing region.
In accordance with the univariate features, joint histogram analysis showed that Voxel Group IV (increased DTI-p/decreased DTI-q, p↑/q↓) accounted for the largest proportion in both contrast-enhancing and non-enhancing regions. A significantly higher proportion of Voxel Group IV (p↑/q↓) was found in contrast-enhancing region than non-enhancing region (p < 0.001). By contrast, non-enhancing region displayed significantly higher proportion of Voxel Group II (p↓/q↑) and Voxel Group III (p↑/q↑) (both p < 0.001) than contrast-enhancing region.
Multivariate survival analysis
The multivariate survival modeling of PFS and OS were tested in 56 patients for whom all confounders including IDH-1 mutation, MGMT methylation status and histogram features were available. The results of the multivariate Cox-regression analysis were shown in Table 3 . Figure   2 , with p values from Log-rank test.
Incremental prognostic value of joint histogram features
The results of model comparisons were shown in Table 4 . 
Correlations with tumor progression rate and FLAIR volume
Further, we performed correlation tests in above 3 of 8 joint histogram features which showed significantly incremental diagnostic accuracy. First, the correlation with tumor progression rate was tested in 57 patients had progression and with available MR images at progression. The progression volume (mean ± SD) was 14.32 ± 21.97 
Discussion
In this study, we found that preoperative joint histogram analysis using DTI-p and -q can reflect the heterogeneity of tumor infiltration. The histogram features obtained with this method can improve the prognostic value of IDH-1 mutation and MGMT promoter methylation status, and be useful in detection of tumor subregion which might be responsible for progression.
Previous studies have shown that DTI has potential in studying tumor infiltration (25) .
However, the interpretation of tensor data is challenging, due to the high dimensionality. Substantial efforts have been made to simplify the tensor data into scalar measures. Among these markers, fractional anisotropy (FA) and mean diffusivity (MD) are most commonly used (11) . However, since FA can be affected by both the anisotropic and isotropic components (according to its definition equation), its utility is not consistent in detecting tumor infiltration. An enhanced visualization and quantification of tensor imaging was subsequently advanced by decomposing the raw tensor into isotropic (p) and anisotropic (q) components (7) . This technique has shown its utility in detecting the subtle change caused by tumor invasion and predicting progression (17) . Consistent with previous studies, our results showed an increased DTI-p and decreased DTI-q in most univariate histogram features, which have been previously shown to be biomarkers of bulk tumour and invasive tumour.
However, our results also suggested non-enhancing tumor region may display increased mean and 75th percentile of DTI-q.
One single marker is insufficient to reflect the full tensor. Moreover, it is suggested to combine DTI measures with structural imaging modalities (26) . To achieve this, we proposed the current joint histogram analysis of DTI-p and -q within the tumor regions identified on anatomical sequences. The results showed the Voxel Group IV (p↑/q↓) had the largest proportion. In this subregion, the brain microstructure was displaced to allow more isotropic movement of water molecules. The displacement of fibers also means the 'fast track' to infiltrate was diminishing and thus lead to the decreased anisotropic movement. The significantly higher proportion of this diffusion pattern in the bulk tumor than the infiltrated tumor may suggest more substantial fiber damage within the bulk tumor.
More diffusion patterns can be revealed by this approach. Particularly, the higher proportions of Voxel Group II (p↓/q↑) and Voxel Group III (p↑/q↑) in the nonenhancing region may suggest a less disrupted white matter tract. In these regions, water molecules tend to behave higher anisotropic movement. Since the decreased DTI-p is thought to reflect the elevated cell density, the tumor subregion identified by Voxel Group II (p↓/q↑) in non-enhancing region, may represent a migratory tumor habitat with higher cellularity. Though the proportion is relatively low, the contribution to patient survival and tumor progression rate indicated its higher invasiveness and should be treated with more attention in surgical planning. As shown in the case example, the location of this subregion is in the vicinity of surgical cavity, an extended resection might be considered for these subregions. Histological correlation of these findings is required.
The joint histogram features found in our study showed clinical significance, with incremental prognostic values when integrated over clinical factors. As the more invasive subregion identified, targeted tumor resection and radiation therapy can perhaps be achieved, which may reduce the radiation damage to the normal brain and enhance the efficacy of treatment. Also, this proposed approach may be applied to a broader imaging research field to meet the demand of multiple modality imaging analysis.
There are some limitations in our study. Firstly, the patient population reported is from a single center and the results were not validated by another cohort. Secondly, although our current study did not have biological validation, previous studies have validated the histological correlates of DTI-p and DTI-q by image-guided biopsies (8) .
This current study presented more comprehensive measure of tumor infiltration with the joint analysis of these two directional components.
In conclusion, we used a novel approach of joint histogram analysis of DTI-p and -q.
The results showed that the joint histogram analysis may help to better understand the heterogeneity of tumor infiltration; the decreased DTI-p and increased DTI-q in non-enhancing region may be able to define an invasive subregion responsible for tumor progression. This finding may be useful in targeted surgery and radiation therapy. . The patient received tumor resection with the guidance of neuronavigation and 5-aminolevulinic acid fluorescence with the aim of maximal resection, but only subtotal resection was achieved according to 72h post-operative MRI. Pathological assessment confirmed this was a MGMT-methylated glioblastoma and IDH mutation was negative. The patient received concomitant and adjuvant temozolomide chemoradiotherapy. The progression-free survival of this patient was 47 days and overall survival was 104 days. The post-contrast T1-weighted imaging showed the progression was around the resection cavity (C). The joint histogram analysis of pre-operative DTI-p (D) and DTI-q (E) maps showed Voxel Group II occupied 15.54% in the non-enhancing tumor and Voxel Group IV occupied 28.24 % of the non-enhancing tumor (F). The subregion of Voxel Group II in the non-enhancing tumor (yellow) corresponded to the progression location. . Volumetric analysis showed contrast enhanced tumor volume was 37.39 cm 3 . Gross total resection was achieved in this patient with the guidance of neuronavigation and 5-aminolevulinic acid fluorescence. Pathological assessment confirmed a MGMT-methylated glioblastoma and IDH mutation was negative. The patient received concomitant and adjuvant temozolomide chemoradiotherapy. The progression-free survival of this patient was 1006 days and was alive in the last follow-up. Post-contrast T1-weighted imaging showed a minor progression around the resection cavity (C). The joint histogram analysis of pre-operative DTI-p (D) and DTI-q (E) maps showed Voxel Group II occupied 2.29 % of the non-enhancing tumor and Voxel Group IV occupied 81.45 % of the non-enhancing tumor (F).
